Despite advancements in oncology across the country, many patients still encounter barriers that limit access and outcomes. Economic disparity, education, geography, and social biases, whether related to gender, age, disability, ethnicity, or lifestyle, continue to shape inequality in cancer care.
As the largest hospital network in Indonesia with 41 locations, Siloam Hospitals Group is committed to changing that landscape. Through MRCCC Siloam Hospitals Semanggi, the group drives national efforts in cancer prevention, early detection, treatment innovation, and community awareness aligned with the Ministry of Health's transformation agenda.
The Siloam Oncology Summit serves as a catalyst, a space where collaboration, scientific advancement, and shared vision come together to elevate cancer care in Indonesia and beyond.
This sixth edition of the Summit offers:
Leading specialists from world-renowned cancer institutions will share breakthrough findings and clinical advancements through impactful plenary sessions shaping the future of oncology.
• Hands-on training sessions in advanced procedures, including digestive endoscopic ultrasound (EUS).
• Workshops on palliative care designed to reinforce holistic, patient-centered practice.
• Additional clinical and multidisciplinary workshops tailored to strengthen healthcare teams.
Practical, implementable frameworks to strengthen cancer care, from clinical practice to organizational strategy and public health impact, delivered through 24 focused symposium sessions.
A platform for clinicians, researchers, and students to showcase forward-thinking ideas and innovations that can accelerate progress in cancer care.
Join us at The 6th Siloam Oncology Summit 2026, where leading oncology experts from around the world gather to share cutting-edge research, clinical insights, and innovative approaches to cancer care.
This summit offers a unique opportunity to engage in multidisciplinary discussions, explore personalized treatment strategies, and network with healthcare professionals dedicated to advancing oncology services in the Asia-Pacific region.